Source: Polaris Market Research Analysis Segmental Insights By Type of GLP-1 Agonist Drugs Analysis The segmentation, based on type of GLP-1 agonist drugs, includes long-acting GLP-1 agonist and short-acting GLP-1 agonist
GLP-1-based therapies, such as GLP-1 receptor agonists, glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, and dipeptidyl peptidase 4 (DPP-4) inhibitors, improve glucose control through various mechanisms including increased insulin secretion, slower gastric emptying, and reduced postprandial glucagon and food intake
The Danger: If you lose 20 lbs, and 8 lbs of that is muscle, you have actually slowed down your metabolism
Generally, elderly patients diagnosed with type 2 diabetes or obesity can safely take semaglutide to improve glycemic control and curb the risk of cardiovascular events
Refrigerate immediately once reconstituted, and use within 28 days
Many people worry that they will accidentally hurt themselves or ruin their treatment